ARCINOVA
Their innovative approach, agility and flexibility enables us to overcome project challenges and save our customers valuable time - enabling them to bring life-changing medicines to market more rapidly and cost-effectively.They work with big pharma, speciality pharma and biotech companies across the world, from established multinationals to emerging start-ups.
ARCINOVA
Industry:
Biotechnology Chemical
Founded:
2015-01-01
Address:
Alnwick, Northumberland, United Kingdom
Country:
United Kingdom
Website Url:
http://www.arcinova.uk
Total Employee:
101+
Status:
Closed
Contact:
01665 608 300
Total Funding:
5 M GBP
Technology used in webpage:
Amazon
Current Employees Featured
Founder
Investors List
Business Growth Fund
Business Growth Fund investment in Venture Round - Arcinova
More informations about "Arcinova"
Arcinova has been rebranded to Quotient Sciences
NOTTINGHAM, U.K.; July 1, 2021 – Quotient Sciences, the drug development and manufacturing accelerator, announces that it has completed the rebrand of Arcinova, the Alnwick U.K.-based contract development and manufacturing …See details»
Quotient Sciences Acquires Arcinova
Professor Ian Shott, CBE, co-founder and executive chairman of Arcinova, said: “Since inception, we set out to build a unique organization that accelerates the development of new medicines for patients in need. We are delighted to move …See details»
Quotient Sciences Acquires Arcinova, the UK-Based …
Feb 9, 2021 Arcinova is a multiservice contract development and manufacturing organization (CDMO) that serves pharmaceutical and biotechnology companies across the globe in developing their life changing ...See details»
Quotient Sciences Acquires Arcinova, the UK-Based Contract
Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing …See details»
Quotient Sciences Acquires Arcinova, the UK-Based Contract …
Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing …See details»
Quotient Sciences acquires Arcinova, a UK CDMO
Feb 15, 2021 Quotient Sciences, the drug development and manufacturing accelerator, has acquired Arcinova, the UK-based multiservice contract development and manufacturing organisation (CDMO). With over 40 years of …See details»
Quotient Sciences acquires Arcinova
Feb 10, 2021 Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the UK-based multi service contract development and manufacturing organisation (CDMO) With more …See details»
More than a CRO | Quotient Sciences - arcinova.com
Quotient Sciences is more than a global contract research organization (CRO). We deliver clinical expertise, integrated and tailored for your drug product's success.See details»
Bionow | Arcinova has now been rebranded to Quotient Sciences
Jul 1, 2021 Quotient acquired Arcinova in February 2021 with the strategic goal of providing an “end to end” offering for customers and creating further differentiation for Quotient in the …See details»
Drugs company Quotient Sciences takes over Alnwick-based …
Feb 10, 2021 Arcinova’s facility in Alnwick, where more than 160 staff are employed, is now one of the most technically advanced of its kind in the UK. Arcinova has been acquired by Quotient …See details»
Quotient Sciences Acquires Arcinova, the UK-Based Contract …
Feb 9, 2021 Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development …See details»
Quotient Sciences Acquires CDMO Arcinova - pharmtech.com
Feb 17, 2021 Quotient Sciences, a UK-based drug development and manufacturing accelerator, announced on Feb. 9, 2021 that it has acquired Arcinova, a UK-based multiservice contract …See details»
Society of Chemical Industry - Quotient Sciences acquires Arcinova
Feb 10, 2021 Arcinova, the UK-based multiservice contract development and manufacturing organisation, has been acquired by Quotient Sciences, the drug development and …See details»
Quotient acquisition of Arcinova aimed at ‘streamlining’ early ...
Feb 18, 2021 Arcinova’s drug substance capability enables Quotient to engage with customers at the point of candidate selection. By closely integrating the drug substance to drug product …See details»
Arcinova - A Quotient Sciences business - LinkedIn
Arcinova is an agile Contract Development & Manufacturing Organisation (CDMO), providing the pharmaceutical industry with integrated and specialist services, throughout the drug …See details»
PRESS RELEASE Quotient Sciences Acquires Arcinova, the UK …
Manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of …See details»
Quotient Sciences Acquires Arcinova, the UK-Based Contract …
Feb 9, 2021 NOTTINGHAM, England--(BUSINESS WIRE)--Feb 9, 2021-- Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired …See details»
Alnwick Introduction - Quotient Sciences
In February 2021, Quotient Sciences acquired the contract development and manufacturing organization (CDMO) Arcinova, based in the north-east of England and now known as …See details»
Quotient Sciences Acquires CDMO Arcinova
Feb 17, 2021 Quotient Sciences, a UK-based drug development and manufacturing accelerator, announced on Feb. 9, 2021 that it has acquired Arcinova, a UK-based multiservice contract …See details»
Arcinova - Crunchbase Company Profile & Funding
Arcinova is a pharmaceutical research and development process Company. Their innovative approach, agility and flexibility enables us to overcome project challenges and save our …See details»